Switzerland could also be targeted by the new US President Donald Trump. According to a study by the major bank UBS, the pharmaceutical industry in ...

Professor Saoirse O’Sullivan, Vice President Translational Science at Artelo Biosciences, is scheduled to deliver a presentation entitled, “A Cannabidiol Cocrystal (ART12.11) Tablet Has Comparable ...

Combat Counterfeit Medications: SwissRx Coin introduces a blockchain-based traceability system that tracks and verifies the ...

Thomas Schinecker, CEO of Swiss pharma firm Roche, has dismissed fears that sales targets would be under threat by US tariffs.

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Munich, ...

Current CFO Andrew Smith to step down after five years with Santhera, and will support an orderly transition ...

Israel – a country that receives almost half of its research and development investments from foreign capital – is a striking example of how international financing can contribute to the strength of ...

NEW YORK, Jan. 23, 2025 /PRNewswire/ -- Alnylam Pharmaceuticals ... Consul General of Switzerland, and Artur Czerniejewski, Director of the Swiss Business Hub USA, in a ceremony highlighting ...

Alys Pharmaceuticals, Inc. ("Alys"), an immune-dermatology focused company, today announces that the U.S. Food and Drug Administration (FDA) and Health Canada have cleared the Investigational New Drug ...